Enlightify (ENFY) notified NYSE of intent to cure $1.00 minimum price deficiency; 6-month cure period.

Enlightify Inc.

NYSE notified Enlightify on Aug 27, 2025 that average closing price fell below $1.00 over 30 days.
Company submitted letter on Sept 9, 2025 of intent to cure; six-month window (subject to extension) to regain compliance.
Common stock continues trading on NYSE during cure period; business operations and SEC reporting unaffected.
No default triggered under material debt or other agreements.

item 3.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.